7連板英特集團(000411.SZ)巨震!疫苗冷鏈在手訂單僅5萬元 上半年淨利同比降17.73%
格隆匯8月5日丨此前因疫苗冷鏈概念炒作走出7連板的英特集團(000411.SZ)在昨天打開漲停板後,今天早盤以跌停開盤,但隨着整個醫藥體系類股集體走高,該股半小時不到跌停板被打開,之後一路震盪向上一度漲超8%,振幅高達18.29%,目前漲幅為1.6%。公司日前公告,2020年上半年第三方醫藥冷鏈物流業務收入僅佔公司主營業務收入的0.0076%,目前公司第三方醫藥冷鏈物流業務的在手訂單金額僅為5萬元,不會對公司經營業績產生重大影響。另外,昨晚公司發佈業績快報顯示,上半年營收118.66億元,同比增0.57%;歸母淨利潤8008萬元,同比降17.73%。公司資產結構及主營業務未發生重大變化,主營業務收入主要來源於藥品、醫療器械批發和零售業務。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.